Related references
Note: Only part of the references are listed.Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease
Taylor W. Schmitz et al.
JOURNAL OF NEUROSCIENCE (2020)
Plasma tau correlateswith basal forebrain atrophy rates in people at risk for Alzheimer disease
Enrica Cavedo et al.
NEUROLOGY (2020)
Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors
Shuko Takeda
NEUROSCIENCE RESEARCH (2019)
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults
Donna M. Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Carol A. C. Coupland et al.
JAMA INTERNAL MEDICINE (2019)
Normal and Pathological Tau Uptake Mediated by M1/M3 Muscarinic Receptors Promotes Opposite Neuronal Changes
Viktoriya Morozoya et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population
David T. Gamble et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Review: Vascular dementia: clinicopathologic and genetic considerations
H. V. Vinters et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Spinal cholinergic interneurons differentially control motoneuron excitability and alter the locomotor network operational range
Maria Bertuzzi et al.
SCIENTIFIC REPORTS (2018)
Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways
Lewis D. Evans et al.
CELL REPORTS (2018)
Longitudinal Alzheimer's Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections
Taylor W. Schmitz et al.
CELL REPORTS (2018)
Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV
M. Aghourian et al.
MOLECULAR PSYCHIATRY (2017)
CHOLINERGIC CIRCUITS IN COGNITIVE FLEXIBILITY
Vania F. Prado et al.
NEUROSCIENCE (2017)
Structure of Rap1b bound to talin reveals a pathway for triggering integrin activation
Liang Zhu et al.
NATURE COMMUNICATIONS (2017)
All muscarinic acetylcholine receptors (M1-M5) are expressed in murine brain microvascular endothelium
Beatrice Mihaela Radu et al.
SCIENTIFIC REPORTS (2017)
AF710B, a Novell M1/sigma 1 Agonist With Therapeutic Efficacy on Animal Models of Alzheimer's Disease
Abraham Fisher et al.
NEURODEGENERATIVE DISEASES (2016)
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
Shannon L. Risacher et al.
JAMA NEUROLOGY (2016)
Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase
Maria-Letizia Campanari et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions
Satoshi Sugita et al.
SKELETAL MUSCLE (2016)
Does Anticholinergic Activity Affect Neuropathology? Implication of Neuroinflammation in Alzheimer's Disease
Yasumasa Yoshiyama et al.
NEURODEGENERATIVE DISEASES (2015)
Cumulative Use of Strong Anticholinergics and Incident Dementia A Prospective Cohort Study
Shelly L. Gray et al.
JAMA INTERNAL MEDICINE (2015)
Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis
Antonia Kaltsatou et al.
BBA CLINICAL (2015)
Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up
N. Yildiz et al.
SPINAL CORD (2014)
Regulation of cholinergic activity by the vesicular acetylcholine transporter
Vania F. Prado et al.
BIOCHEMICAL JOURNAL (2013)
Cholinergic Dysfunction in Parkinson's Disease
Martijn L. T. M. Mueller et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Colovic et al.
CURRENT NEUROPHARMACOLOGY (2013)
Systematic review of anticholinergic risk scales in older adults
Carlos E. Duran et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Lars Brichta et al.
TRENDS IN NEUROSCIENCES (2013)
The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology
Diana Simon et al.
FRONTIERS IN NEUROLOGY (2013)
Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model
Yasumasa Yoshiyama et al.
NEUROBIOLOGY OF DISEASE (2012)
Cholinergic modulation of cognitive processing: insights drawn from computational models
Ehren L. Newman et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2012)
The Selective M1 Muscarinic Cholinergic Agonist CDD-0102A Enhances Working Memory and Cognitive Flexibility
Michael E. Ragozzino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease-Like Pathology and Cognitive Decline
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice
Adrian Gericke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Drugs with anticholinergic properties: a current perspective on use and safety
Philip Gerretsen et al.
EXPERT OPINION ON DRUG SAFETY (2011)
Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo
Albert A. Davis et al.
JOURNAL OF NEUROSCIENCE (2010)
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population The 3-City Study
Isabelle Carriere et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
The anticholinergic risk scale and anticholinergic adverse effects in older persons
James L. Rudolph et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Anticholinergic activity of 107 medications commonly used by older adults
Marci L. Chew et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity
Ryan M. Carnahan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001
JJ Sejvar et al.
NEUROEPIDEMIOLOGY (2005)
Choline transporters, cholinergic transmission and cognition
M Sarter et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
LR Fischer et al.
EXPERIMENTAL NEUROLOGY (2004)
Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus
A Sato et al.
NEUROSCIENCE LETTERS (2004)
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease - An in vivo positron emission tomographic study
NI Bohnen et al.
ARCHIVES OF NEUROLOGY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice
M Yamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Alzheimer's disease: Genes, proteins, and therapy
DJ Selkoe
PHYSIOLOGICAL REVIEWS (2001)
Share Paper
